BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2284285)

  • 1. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
    Chisholm GD
    Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
    [No Abstract]   [Full Text] [Related]  

  • 2. Reasons for delay of endocrine treatment in cancer of the prostate (until symptomatic metastases occur).
    Christensen MM; Aagaard J; Madsen PO
    Prog Clin Biol Res; 1990; 359():7-14; discussion 15-24. PubMed ID: 2284298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract]   [Full Text] [Related]  

  • 5. Bilateral orchiectomy in the management of stage D-2 prostate cancer.
    Guinan P; Firfer R; Targonski P; Rubenstein M
    Int Surg; 1993; 78(1):73-5. PubMed ID: 8473090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why not neo-adjuvant therapy for prostatic carcinoma?
    Fair WR
    Prog Clin Biol Res; 1991; 370():305-12. PubMed ID: 1924464
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
    Servadio C
    Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
    [No Abstract]   [Full Text] [Related]  

  • 9. Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
    Lu-Yao G; Moore DF; Oleynick JU; DiPaola RS; Yao SL
    J Urol; 2007 Feb; 177(2):535-9. PubMed ID: 17222628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.
    Zagars GK; Pollack A; von Eschenbach AC
    Cancer; 1997 Aug; 80(4):764-75. PubMed ID: 9264361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP; Slack NH
    Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer.
    Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T
    Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal management of advanced adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839
    [No Abstract]   [Full Text] [Related]  

  • 14. Early versus delayed endocrine treatment in metastatic prostatic cancer.
    Schröder FH
    Prog Clin Biol Res; 1989; 303():253-60. PubMed ID: 2674988
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metastatic prostate carcinoma].
    Smith MR; Kantoff P; Talcott J
    Praxis (Bern 1994); 2001 Sep; 90(38):1653-8. PubMed ID: 11675919
    [No Abstract]   [Full Text] [Related]  

  • 16. Can prostatectomy add any benefit to the hormonal treatment of stage C prostatic carcinoma?
    Schröder FH
    Prog Clin Biol Res; 1989; 303():241-52. PubMed ID: 2780650
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
    Mayer FJ; Crawford ED
    Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: metastatic.
    Michaelson D; Talcott J; Smith M
    Clin Evid; 2002 Jun; (7):804-11. PubMed ID: 12230706
    [No Abstract]   [Full Text] [Related]  

  • 19. [Castration in the treatment of locally advanced or metastatic prostate cancer].
    Mongiat-Artus P
    Rev Prat; 2013 Apr; 63(4):509-10. PubMed ID: 23682480
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal treatment of advanced disease: some newer aspects.
    Griffiths K; Eaton CL; Harper ME; Turkes A; Peeling WB
    Semin Oncol; 1994 Oct; 21(5):672-87. PubMed ID: 7939755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.